The Upside Story Behind Concentra Group Holdings Parent, Inc. (CON)

Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Concentra Group Holdings Parent, Inc. (NYSE:CON) has a “Buy” or equivalent rating from all seven analysts covering the stock. While the target price ranges from $25 to $31, the median price target of $29 implies an upside potential of 48.95% from the current price.

After Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its third-quarter results on November 6, several analysts reaffirmed their bullish outlook on the company. On November 10, Mizuho Securities maintained a Buy rating on the stock, with an unchanged price target of $28. Three days earlier, Joanna Gajuk, an analyst at Bank of America Securities, maintained a Buy rating on the company.

In the third quarter, Concentra Group Holdings Parent, Inc. (NYSE:CON) reported increases in revenue, net income, and adjusted EBITDA of 17%, 8.9%, and 17.1%, respectively. Additionally, the company recorded a rise not only in revenue per visit but also in patient volumes.

As stated by Keith Newton, CEO of Concentra Group Holdings Parent, Inc. (NYSE:CON),

“Building on our business growth in the first half of the year, our strong third quarter results delivered year-over-year increases in revenue, net income, and Adjusted EBITDA driven by visit and rate growth, as well as executing on our inorganic strategy.”

Concentra Group Holdings Parent, Inc. (NYSE:CON), based in Addison, Texas, is a provider of occupational health services in the U.S. Founded in 1979, the company operates Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration.

While we acknowledge the potential of CON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.